Cargando…
Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study
BACKGROUND: Coronavirus disease (COVID-19) is an infectious disease due to SARS-COV-2. Patients with risk factors are vulnerable to severe morbidity and mortality. Favipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19 treatments. OBJECTIVE: To investigate the effectiveness...
Autores principales: | Alotaibi, Musim, Ali, Ahmed, Bakhshwin, Duaa, Alatawi, Yasser, Alotaibi, Sultan, Alhifany, Abdullah, Alharthi, Badr, Alharthi, Nasser, Alyazidi, Awatef, Alharthi, Yasmeen, Alrafiah, Aziza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449635/ https://www.ncbi.nlm.nih.gov/pubmed/34548811 http://dx.doi.org/10.2147/IJGM.S329881 |
Ejemplares similares
-
Mortality Predictors Among COVID-19 Elderly in Taif, Saudi Arabia
por: Bakhshwin, Duaa, et al.
Publicado: (2022) -
Trimethoprim/sulfamethoxazole‐induced methemoglobinemia in pediatric patient: A case report
por: Alotaibi, Sultan, et al.
Publicado: (2023) -
A Rare Case of Atypical Fibroxanthoma of the Thigh in an Elderly Patient
por: Alotaibi, Yaser, et al.
Publicado: (2023) -
Jacquet erosive diaper dermatitis in a child with COVID-19
por: Alotaibi, Hend M, et al.
Publicado: (2023) -
Knowledge of Saudi Patients with Autoimmune Diseases about Hydroxychloroquine Toxicity: The Role of Physician–Patient Communication
por: Aldarwesh, Amal, et al.
Publicado: (2022)